JG
HAE icon

Jefferies Group’s Haemonetics HAE Stock Holding History

Jefferies Group’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-39,319
Closed -$2.78M – 1779
2021
Q3 		$2.78M Buy
+39,319
New +$2.48M 0.02% 633
2020
Q2 		– Sell
-25,000
Closed -$2.49M – 1617
2020
Q1 		$2.49M Buy
25,000
+20,054
+405% +$2.17M 0.03% 578
2019
Q4 		$568K Buy
4,946
+2,111
+74% +$255K ﹤0.01% 1732
2019
Q3 		$358K Sell
2,835
-24,536
-90% -$3.11M ﹤0.01% 2076
2019
Q2 		$3.29M Buy
27,371
+22,274
+437% +$2.19M 0.02% 674
2019
Q1 		$446K Buy
5,097
+2,491
+96% +$227K ﹤0.01% 1642
2018
Q4 		$261K Buy
2,606
+600
+30% +$63K ﹤0.01% 1717
2018
Q3 		$230K Buy
+2,006
New +$208K ﹤0.01% 2033
2018
Q1 		– Sell
-50,039
Closed -$2.91M – 2429
2017
Q4 		$2.91M Buy
+50,039
New +$2.63M 0.01% 802

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
LCP
LGT Capital Partners Pfaeffikon, Switzerland $1.88B AUM 20.37% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Jefferies Group's HAE Position: Q4 2021 in Review

Jefferies Group sold out of Haemonetics (HAE) in Q4 2021, closing a stake of 39,319 shares — an estimated $2.78M sold.

Jefferies Group first reported a position in HAE in Q4 2017 and held it in 9 quarters. The position peaked at $3.29M in Q2 2019. 257 funds tracked by Wall St. Rank hold HAE as of Q4 2021.

  • Jefferies Group reported no remaining Haemonetics position as of Q4 2021 after selling out during the quarter.
  • Jefferies Group sold 39,319 Haemonetics shares in Q4 2021, an estimated $2.78M.
  • Jefferies Group first reported a position in Haemonetics in Q4 2017 and held it in 9 quarters.
  • Jefferies Group's Haemonetics position peaked at $3.29M in Q2 2019.
  • 257 funds tracked by Wall St. Rank held Haemonetics as of Q4 2021.

Based on Jefferies Group's 13F filing for Q4 2021, filed 14 Feb 2022.